BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Avian flu virus
,
Lipitor
,
rs4950928
,
SNCA
,
Metabolism of xenobiotics
,
Arthritis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
2- cell- gene labeled cells
Summary
General Info
Curated Studies
Most Correlated Studies
Macrophage 4sU-labeled and total RNA after MEN1 or WDR82 shRNA knockdowns and LPS treatment
Hematopoietic stem cells marked for division histories via label retention
Sweat gland cells label (H2B-GFP) retaining or non-retaining
Colonocytes and enterocytes profiled with differentiated colon cancer cell lines
Granulocyte progenitors, pro-erythroblasts, and hematopoietic stem cells from Lsd1-knockout mice
Explore Curated Studies Results
Literature
Most Relevant Literature
The cysteine-rich with EGF-like domains 2 (CRELD2) protein interacts with the large cytoplasmic doma…
Nicotinic acetylcholine receptor distribution in relation to spinal neurotransmission pathways.
ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting v…
Distribution of alpha 2, alpha 3, alpha 4, and beta 2 neuronal nicotinic receptor subunit mRNAs in t…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Gene Therapy Using Anti-Her-2 Cells to Treat Metastatic Cancer
Stem Cell Gene Therapy for Sickle Cell Disease
Pilot and Feasibility Study of Hematopoietic Stem Cell Gene Transfer for the Wiskott-Aldrich Syndrom…
Phase I/II Clinical Trial Stem Cell Gene Therapy in RAG1-Deficient SCID
Treatment of B-CLL With Human IL-2 and CD40 Ligand and Plasmid Gene Modified Autologous Tumor Cells
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ